MBC-11

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameMBC-11
Drug Alias NameCytarabine/etidronic acid,Etidronic acid/cytarabineMBC-11MBC-11-29
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBone resorption factor inhibitorsDNA synthesis inhibitors
TargetsBone resorption factor
Therapy Area/IndicationsBone metastases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMbc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOsteros Biomedica Ltd
Active IndicationsN/A
Inactive IndicationsBone metastases

Other Information

ATC CodeN/A
Related LinksN/A